2.02 USD
▼+0.36-2.42%
盘后 2.15 +3.86%
2026-08-03
市值
$1.48M
市盈率
—
EPS
-39.60
股息率
—
52 周区间
1.43 – 61.25
成交量
172.55K
Beta
1.82
目标价
—
52W 低 1.4352W 高 61.25
价格走势
公司简介
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company’s pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced ...